Category: Hepatitis C
Six-Week Therapy for Hepatitis C Virus
G&H How has the duration of hepatitis C virus treatment evolved over time? DB Hepatitis C virus (HCV) treatment has seen a tremendous evolution, from interferon, […]
Identification of People Infected With Hepatitis C Virus Who Have Never Been Diagnosed
G&H What is the current prevalence of hepatitis C virus infection in the United States? KK A recent population-based survey of the United States found […]
Update on the Management of Hepatitis C Virus Infection in the Setting of Chronic Kidney Disease and Kidney Transplantation
Abstract: Hepatitis C virus (HCV) infection is one of the major global health burdens. Chronic HCV infection can increase the risks of proteinuria and chronic […]
Hepatitis C Virus Detection and Treatment in Rural Communities
G&H What explains the increase in hepatitis C virus infection in rural communities? SG Over the past decade, an epidemic of hepatitis C virus (HCV) […]
Care of Patients Following Cure of Hepatitis C Virus Infection
Abstract: The vast majority of persons with chronic hepatitis C virus (HCV) infection will achieve virologic cure with the current direct-acting antiviral therapies. Prevention of […]
Hepatitis C Virus–Viremic Liver Transplantation
G&H For a patient with active hepatitis C virus infection, how do outcomes compare when receiving a liver also infected with active hepatitis C virus […]
Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus
Abstract: Background: Hepatitis C virus (HCV) screening is traditionally performed using an enzyme-linked immunosorbent assay (ELISA), and HCV infection is confirmed by measuring the viral […]
Hepatitis C Virus Treatment in Patients With Chronic Kidney Disease and in Kidney Transplant Recipients
Abstract: An important interplay exists between hepatitis C virus (HCV) infection and chronic kidney disease (CKD). HCV infection is associated with an increased risk of […]
Management of Patients Who Have Achieved Sustained Virologic Response for Hepatitis C Virus Infection
G&H How often is sustained virologic response achieved with the current hepatitis C virus treatment options? PP There are multiple direct-acting antiviral (DAA) regimens currently […]
Shortening Treatment for Hepatitis C Virus Infection
G&H How has treatment duration changed from the first direct-acting antiviral agents to those currently being used in patients with hepatitis C virus infection? SK […]
Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders
Abstract: The emergence of direct-acting antiviral (DAA) therapies and noninvasive measures of liver fibrosis has streamlined the management of patients with chronic hepatitis C virus […]
Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection
Abstract: In 2016, the US Food and Drug Administration issued a warning about the risk of hepatitis B virus (HBV) reactivation in some patients receiving […]
Extrahepatic Benefits Achieved With Sustained Virologic Response in Patients With Hepatitis C Virus Infection
G&H What are the hepatic benefits achieved with sustained virologic response in patients infected with hepatitis C virus? MK In patients with chronic hepatitis C […]
Hepatitis C Virus and Liver Transplantation
Abstract: Hepatitis C virus (HCV) is a major cause of death from infectious disease and is still the leading indication for liver transplantation in the […]
Hepatitis C Virus Infection in Children
G&H What is the prevalence of hepatitis C virus infection in children? KM In comparison to adults, the prevalence of this disease is relatively low […]
Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States
Abstract: Background and Aims: Approximately half of adults with hepatitis C in the United States do not know their infection status, and the majority of […]
New Therapies for Hepatitis C Virus Infection
Abstract: Approximately 350 million people worldwide are infected with hepatitis C virus (HCV), which is associated with morbidity and mortality related to cirrhosis, hepatocellular carcinoma, […]